Localization | 2016.03.29
Emulate, Inc. Secures $28 Million Series B Financing to Commercialize its Organs-on-Chips Technology into a Lab-Ready System; Enabling Human-Relevant R&D to Improve Drug Development and Consumer Product Design
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Emulate Inc. has secured $28 million of its Series B financing that will accelerate translation of its Organs-on-Chips technology into a commercially available ‘Human Emulation System’.
For more information, please visit
http://www.businesswire.com/news/home/20[...]Series-Financing-Commercialize
